Global Information
회사소개 | 문의 | 비교리스트

세계의 유방생검 기기 시장(2020-2024년)

Global Breast Biopsy Devices Market 2020-2024

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2020년 06월 상품 코드 946850
페이지 정보 영문 120 Pages
가격
US $ 2,500 ₩ 2,938,000 PDF (Single User License)
US $ 3,000 ₩ 3,525,000 PDF (5-user License)
US $ 4,000 ₩ 4,700,000 PDF (Enterprise License)
US $ 5,000 ₩ 5,876,000 PDF (Global License)


세계의 유방생검 기기 시장(2020-2024년) Global Breast Biopsy Devices Market 2020-2024
발행일 : 2020년 06월 페이지 정보 : 영문 120 Pages

세계의 유방생검 기기 시장은 2020-2024년간 5억 494만 달러 성장하고, 예측기간 동안 10%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

유방암 발병률 증가, M&A 증가에 의해 시장 성장이 견인되고 있습니다.

세계의 유방생검 기기(Breast Biopsy Devices) 시장을 조사했으며, 시장 상황 및 규모, Five Forces 분석, 제품별·최종사용자별·모달리티별 시장 세분화, 고객 및 지역 상황, 공급업체 상황, 벤더 분석 등의 정보를 전해드립니다.

목차

개요

시장 상황

시장 규모

  • 시장의 정의
  • 시장 부문 분석
  • 시장 규모(2019년)
  • 시장 전망 : 예측(2019-2024년)

Five Forces 분석

시장 세분화 : 제품별

  • 시장 세분화
  • 제품별 비교
  • 생검 바늘/시스템 : 시장 규모 예측(2019-2024년)
  • 생검 영상 유도 시스템 : 시장 규모 예측(2019-2024년)
  • 기타 : 시장 규모 예측(2019-2024년)
  • 제품별 시장 기회

시장 세분화 : 최종사용자별

  • 시장 세분화
  • 병원
  • 외래수술센터(ASC)
  • 유방암 전문센터 및 클리닉
  • 기타

시장 세분화 : 모달리티별

  • 시장 세분화
  • 정위 X선 초음파 가이드 생검
  • 초음파 가이드 생검
  • MRI 초음파 가이드 생검

고객 상황

  • 고객 상황

지역별 상황

  • 지역별 세분화
  • 지역별 비교
  • 북미 : 시장 규모 예측(2019-2024년)
  • 유럽 : 시장 규모 예측(2019-2024년)
  • 아시아 : 시장 규모 예측(2019-2024년)
  • 기타 지역 : 시장 규모 예측(2019-2024년)
  • 주요 국가
  • 지역별 시장 기회
  • 시장 성장 촉진요인
  • 시장의 과제
  • 시장 동향

벤더 상황

  • 개요
  • 파괴적 혁신 상황

벤더 분석

  • 대상 벤더
  • 벤더의 시장 포지셔닝
  • Argon Medical Devices Inc.
  • Carestream Health Inc.
  • Danaher Corp.
  • FUJIFILM Holdings Corp.
  • General Electric Co.
  • Hologic Inc.
  • Planmed Oy
  • Scion Medical Technologies LLC
  • Siemens Healthineers AG

부록

LSH 20.07.21

Technavio has been monitoring the breast biopsy devices market and it is poised to grow by $ 504.94 mn during 2020-2024 progressing at a CAGR of 10% during the forecast period. Our reports on breast biopsy devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of breast cancer cases and increasing number of M&As. In addition, growing prevalence of breast cancer cases is anticipated to boost the growth of the market as well.

The breast biopsy devices market analysis includes product segment and geographic landscapes

Technavio's ‘ breast biopsy devices market ’ is segmented as below:

By Product:

  • Biopsy needles and systems
  • Biopsy image-guided systems
  • Others

By Geographic Landscape:

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the increasing number of products showcasing and approvals as one of the prime reasons driving the breast biopsy devices market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our breast biopsy devices market covers the following areas:

  • Breast biopsy devices market sizing
  • Breast biopsy devices market forecast
  • Breast biopsy devices market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading breast biopsy devices market vendors that include Argon Medical Devices Inc., Becton, Dickinson and Co., Carestream Health Inc., Danaher Corp., FUJIFILM Holdings Corp., General Electric Co., Hologic Inc., Planmed Oy, Scion Medical Technologies LLC, and Siemens Healthineers AG. Also, the breast biopsy devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • Biopsy needles and systems - Market size and forecast 2019-2024
  • Biopsy image-guided systems - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by Product

Market Segmentation by End-user

  • Market segments
  • Hospitals
  • ASCs
  • Breast cancer specialty centers and clinics
  • Others

Market Segmentation by Modality

  • Market segments
  • Stereotactic X-ray guided breast biopsy
  • Ultrasound-guided breast biopsy
  • MRI-guided breast biopsy

Customer landscape

  • Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Argon Medical Devices Inc.
  • Carestream Health Inc.
  • Danaher Corp.
  • FUJIFILM Holdings Corp.
  • General Electric Co.
  • Hologic Inc.
  • Planmed Oy
  • Scion Medical Technologies LLC
  • Siemens Healthineers AG

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Key Finding 9
  • 9: Key Finding 10
  • 10: Parent market
  • 11: Market characteristics
  • 12: Offerings of vendors included in the market definition
  • 13: Market segments
  • 14: Global - Market size and forecast 2019 - 2024 ($ million)
  • 15: Global market: Year-over-year growth 2019 - 2024 (%)
  • 16: Five forces analysis 2019 & 2024
  • 17: Bargaining power of buyers
  • 18: Bargaining power of suppliers
  • 19: Threat of new entrants
  • 20: Threat of substitutes
  • 21: Threat of rivalry
  • 22: Market condition - Five forces 2019
  • 23: Product - Market share 2019-2024 (%)
  • 24: Comparison by Product
  • 25: Biopsy needles and systems - Market size and forecast 2019-2024 ($ million)
  • 26: Biopsy needles and systems - Year-over-year growth 2019-2024 (%)
  • 27: Biopsy image-guided systems - Market size and forecast 2019-2024 ($ million)
  • 28: Biopsy image-guided systems - Year-over-year growth 2019-2024 (%)
  • 29: Others - Market size and forecast 2019-2024 ($ million)
  • 30: Others - Year-over-year growth 2019-2024 (%)
  • 31: Market opportunity by Product
  • 32: End user - Market share 2019-2024 (%)
  • 33: Comparison by End user
  • 34: Hospitals - Market size and forecast 2019-2024 ($ million)
  • 35: Hospitals - Year-over-year growth 2019-2024 (%)
  • 36: ASCs - Market size and forecast 2019-2024 ($ million)
  • 37: ASCs - Year-over-year growth 2019-2024 (%)
  • 38: Breast cancer specialty centers and clinics - Market size and forecast 2019-2024 ($ million)
  • 39: Breast cancer specialty centers and clinics - Year-over-year growth 2019-2024 (%)
  • 40: Others - Market size and forecast 2019-2024 ($ million)
  • 41: Others - Year-over-year growth 2019-2024 (%)
  • 42: Market opportunity by End user
  • 43: Other1 - Market share 2019-2024 (%)
  • 44: Comparison by Other1
  • 45: Stereotactic X-ray guided breast biopsy - Market size and forecast 2019-2024 ($ million)
  • 46: Stereotactic X-ray guided breast biopsy - Year-over-year growth 2019-2024 (%)
  • 47: Ultrasound-guided breast biopsy - Market size and forecast 2019-2024 ($ million)
  • 48: Ultrasound-guided breast biopsy - Year-over-year growth 2019-2024 (%)
  • 49: MRI-guided breast biopsy - Market size and forecast 2019-2024 ($ million)
  • 50: MRI-guided breast biopsy - Year-over-year growth 2019-2024 (%)
  • 51: Market opportunity by Other1
  • 52: Customer landscape
  • 53: Market share by geography 2019-2024 (%)
  • 54: Geographic comparison
  • 55: North America - Market size and forecast 2019-2024 ($ million)
  • 56: North America - Year-over-year growth 2019-2024 (%)
  • 57: Europe - Market size and forecast 2019-2024 ($ million)
  • 58: Europe - Year-over-year growth 2019-2024 (%)
  • 59: Asia - Market size and forecast 2019-2024 ($ million)
  • 60: Asia - Year-over-year growth 2019-2024 (%)
  • 61: ROW - Market size and forecast 2019-2024 ($ million)
  • 62: ROW - Year-over-year growth 2019-2024 (%)
  • 63: Key leading countries
  • 64: Market opportunity by geography ($ million)
  • 65: Impact of drivers and challenges
  • 66: Vendor landscape
  • 67: Landscape disruption
  • 68: Industry risks
  • 69: Vendors covered
  • 70: Market positioning of vendors
  • 71: Argon Medical Devices Inc. - Overview
  • 72: Argon Medical Devices Inc. - Product and service
  • 73: Argon Medical Devices Inc. - Key offerings
  • 74: Argon Medical Devices Inc. - Key customers
  • 75: Argon Medical Devices Inc. - Segment focus
  • 76: Becton, Dickinson and Co. - Overview
  • 77: Becton, Dickinson and Co. - Business segments
  • 78: Becton, Dickinson and Co. - Key offerings
  • 79: Becton, Dickinson and Co. - Key customers
  • 80: Becton, Dickinson and Co. - Segment focus
  • 81: Carestream Health Inc. - Overview
  • 82: Carestream Health Inc. - Product and service
  • 83: Carestream Health Inc. - Key offerings
  • 84: Carestream Health Inc. - Key customers
  • 85: Carestream Health Inc. - Segment focus
  • 86: Danaher Corp. - Overview
  • 87: Danaher Corp. - Business segments
  • 88: Danaher Corp. - Key offerings
  • 89: Danaher Corp. - Key customers
  • 90: Danaher Corp. - Segment focus
  • 91: FUJIFILM Holdings Corp. - Overview
  • 92: FUJIFILM Holdings Corp. - Business segments
  • 93: FUJIFILM Holdings Corp. - Key offerings
  • 94: FUJIFILM Holdings Corp. - Key customers
  • 95: FUJIFILM Holdings Corp. - Segment focus
  • 96: General Electric Co. - Overview
  • 97: General Electric Co. - Business segments
  • 98: General Electric Co. - Key offerings
  • 99: General Electric Co. - Key customers
  • 100: General Electric Co. - Segment focus
  • 101: Hologic Inc. - Overview
  • 102: Hologic Inc. - Business segments
  • 103: Hologic Inc. - Key offerings
  • 104: Hologic Inc. - Key customers
  • 105: Hologic Inc. - Segment focus
  • 106: Planmed Oy - Overview
  • 107: Planmed Oy - Product and service
  • 108: Planmed Oy - Key offerings
  • 109: Planmed Oy - Key customers
  • 110: Planmed Oy - Segment focus
  • 111: Scion Medical Technologies LLC - Overview
  • 112: Scion Medical Technologies LLC - Product and service
  • 113: Scion Medical Technologies LLC - Key offerings
  • 114: Scion Medical Technologies LLC - Key customers
  • 115: Scion Medical Technologies LLC - Segment focus
  • 116: Siemens Healthineers AG - Overview
  • 117: Siemens Healthineers AG - Business segments
  • 118: Siemens Healthineers AG - Key offerings
  • 119: Siemens Healthineers AG - Key customers
  • 120: Siemens Healthineers AG - Segment focus
  • 121: Currency conversion rates for US$
  • 122: Research Methodology
  • 123: Validation techniques employed for market sizing
  • 124: Information sources
  • 125: List of abbreviations
Back to Top
전화 문의
F A Q